Is it Finally Time to Buy Medical Properties Trust?
Medical Properties Trust (NYSE:MPW) is a REIT that focuses on…
Sell
43
GBOOF Quote, Financials, Valuation and Earnings
Last price:
$7.34
Seasonality move
:
-1.7%
Day range:
$7.05 - $7.40
52-week range:
$6.10 - $11.29
Dividend yield:
9.33%
P/E ratio:
6.76x
P/S ratio:
1.75x
P/B ratio:
1.68x
Volume:
2.9K
Avg. volume:
39.2K
1-year change:
-31.98%
Market cap:
$20.3B
Revenue:
$12B
EPS (TTM):
$1.07
Analysts' Opinion
-
Consensus RatingNo consensus rating exists at this time due to lack of analyst coverage.
-
Price Target DownsideNo price target exists because of limited analyst coverage.
-
Price Target UpsideSimilarly, at this time, analysts have not provided a price target so downside risk can't be assessed accurately at this time.
Fair Value
-
According to the consensus of 0 analysts, Grupo Financiero Banorte SAB de CV has -- downside to fair value with a price target of -- per share.
GBOOF vs. S&P 500
-
Over the past 5 trading days, Grupo Financiero Banorte SAB de CV has underperformed the S&P 500 by -6.73% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Grupo Financiero Banorte SAB de CV does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Grupo Financiero Banorte SAB de CV revenues have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter Grupo Financiero Banorte SAB de CV reported revenues of $2.7B.
Earnings Growth
-
Grupo Financiero Banorte SAB de CV has grown year-over-year earnings for 2 quarters straight. In the most recent quarter Grupo Financiero Banorte SAB de CV reported earnings per share of $0.24.
Enterprise value:
23.6B
EV / Invested capital:
1.17x
Price / LTM sales:
1.75x
EV / EBIT:
1.29x
EV / Revenue:
2.03x
PEG ratio (5yr expected):
1.89x
EV / Free cash flow:
21.70x
Price / Operating cash flow:
18.76x
Enterprise value / EBITDA:
--
Gross Profit (TTM):
--
Return On Assets:
2.3%
Net Income Margin (TTM):
25.87%
Return On Equity:
21.97%
Return On Invested Capital:
13.96%
Operating Margin:
--
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Income Statement | ||||||
| Revenue | $8.5B | $11.1B | $11.6B | $2.9B | $2.7B | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Operating Income | -- | -- | -- | -- | -- | |
| EBITDA | -- | -- | -- | -- | -- | |
| Diluted EPS | $0.80 | $1.03 | $1.07 | $0.23 | $0.24 | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $10.2B | $7.9B | $11.7B | $13.8B | $9B | |
| Total Assets | $89.9B | $90.4B | $106.2B | $134B | $119.6B | |
| Current Liabilities | $1.8B | $1.6B | $3.5B | $4.2B | $4.2B | |
| Total Liabilities | $78.5B | $78.8B | $93.9B | $119.3B | $107.6B | |
| Total Equity | $11.3B | $11.6B | $12.3B | $14.7B | $12B | |
| Total Debt | $7B | -- | $6.4B | $7.7B | $8.2B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $3.8B | $2.9B | $1.5B | $577.8M | -$1B | |
| Cash From Investing | -$493.4M | -$240.7M | -$218M | -$107.7M | -$113.8M | |
| Cash From Financing | -$2.8B | -$3.1B | -$1.4B | -$978.3M | $1B | |
| Free Cash Flow | $3.2B | $2.4B | $1.1B | $456.2M | -$1.2B | |
GBOOF
Sector
Market Cap
$20.3B
$625.8M
Price % of 52-Week High
63.88%
86.55%
Dividend Yield
9.33%
1.95%
Shareholder Yield
14.03%
3.76%
1-Year Price Total Return
-31.98%
9.43%
Beta (5-Year)
0.716
0.712
Dividend yield:
9.33%
Annualized payout:
$0.67
Payout ratio:
65.54%
Growth streak:
0 years
Technicals
8-day SMA
Sell
Level
$7.35
200-day SMA
Sell
Level
$7.32
Bollinger Bands (100)
Buy
Level
6.72 - 7.4
Chaikin Money Flow
Buy
Level
3.4M
20-day SMA
Sell
Level
$7.28
Relative Strength Index (RSI14)
Sell
Level
48.80
ADX Line
Sell
Level
10.1
Williams %R
Neutral
Level
-53.9954
50-day SMA
Sell
Level
$7.26
MACD (12, 26)
Buy
Level
0.01
25-day Aroon Oscillator
Buy
Level
44
On Balance Volume
Neutral
Level
3.1M
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (0.8677)
Sell
CA Score
(Annual)
Level (-1.5735)
--
Beneish M-Score
(Annual)
Level (--)
--
Momentum Score
Level (--)
Sell
Ohlson Score
Level (0.9479)
--
Piotroski F Score
(Annual)
Level (--)
--
Quality Ratio Score
Level (--)
Buy
Fundamental Score
Level (7)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Grupo Financiero Banorte SAB de CV is a Mexican financial services company. The company offers a wide variety of products and services including banking services, brokerage, wholesale banking, leasing, factoring, insurance, pensions, and retirement savings. It operates locally in Mexico.
Stock Forecast FAQ
In the current month, GBOOF has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The GBOOF average analyst price target in the past 3 months is --.
-
Where Will Grupo Financiero Banorte SAB de CV Stock Be In 1 Year?
According to analysts, the consensus estimate is that Grupo Financiero Banorte SAB de CV share price will drop to -- per share over the next 12 months.
-
What Do Analysts Say About Grupo Financiero Banorte SAB de CV?
Analysts are divided on their view about Grupo Financiero Banorte SAB de CV share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Grupo Financiero Banorte SAB de CV is a Sell and believe this share price will rise from its current level to --.
-
What Is Grupo Financiero Banorte SAB de CV's Price Target?
The price target for Grupo Financiero Banorte SAB de CV over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is GBOOF A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Grupo Financiero Banorte SAB de CV is a --. 0 of 0 analysts rate the stock a -- at this time.
-
How Can I Buy Shares Of GBOOF?
You can purchase shares of Grupo Financiero Banorte SAB de CV via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Grupo Financiero Banorte SAB de CV shares.
-
What Is The Grupo Financiero Banorte SAB de CV Share Price Today?
Grupo Financiero Banorte SAB de CV was last trading at $7.34 per share. This represents the most recent stock quote for Grupo Financiero Banorte SAB de CV. Yesterday, Grupo Financiero Banorte SAB de CV closed at $7.21 per share.
-
How To Buy Grupo Financiero Banorte SAB de CV Stock Online?
In order to purchase Grupo Financiero Banorte SAB de CV stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Did Signet Jewelers Stock Go Up So Much?
Signet Jewelers (NYSE:SIG) is the largest diamond retailer in the…
Why Did HealthEquity Stock Fall So Much?
HealthEquity (NASDAQ:HQY) is a fintech company that acts as an…
Stock Ideas
Buy
56
Is AAPL Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 37x
Buy
53
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Sell
44
Is NVDA Stock a Buy?
Market Cap: $2.7T
P/E Ratio: 38x
Alerts
Buy
69
CNXC alert for Mar 28
Concentrix [CNXC] is down 12.39% over the past day.
Buy
74
SLNO alert for Mar 28
Soleno Therapeutics [SLNO] is up 6.8% over the past day.
Buy
51
CAR alert for Mar 28
Avis Budget Group [CAR] is up 0.71% over the past day.
